Correction to: Will the reformed Cancer Drugs Fund address the most common types of uncertainty? An analysis of NICE cancer drug appraisals

Detalles Bibliográficos
Autores principales: Morrell, Liz, Wordsworth, Sarah, Schuh, Anna, Middleton, Mark R., Rees, Sian, Barker, Richard W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6437939/
https://www.ncbi.nlm.nih.gov/pubmed/30922313
http://dx.doi.org/10.1186/s12913-019-4039-8
_version_ 1783407023457566720
author Morrell, Liz
Wordsworth, Sarah
Schuh, Anna
Middleton, Mark R.
Rees, Sian
Barker, Richard W.
author_facet Morrell, Liz
Wordsworth, Sarah
Schuh, Anna
Middleton, Mark R.
Rees, Sian
Barker, Richard W.
author_sort Morrell, Liz
collection PubMed
description
format Online
Article
Text
id pubmed-6437939
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-64379392019-04-08 Correction to: Will the reformed Cancer Drugs Fund address the most common types of uncertainty? An analysis of NICE cancer drug appraisals Morrell, Liz Wordsworth, Sarah Schuh, Anna Middleton, Mark R. Rees, Sian Barker, Richard W. BMC Health Serv Res Correction BioMed Central 2019-03-28 /pmc/articles/PMC6437939/ /pubmed/30922313 http://dx.doi.org/10.1186/s12913-019-4039-8 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Correction
Morrell, Liz
Wordsworth, Sarah
Schuh, Anna
Middleton, Mark R.
Rees, Sian
Barker, Richard W.
Correction to: Will the reformed Cancer Drugs Fund address the most common types of uncertainty? An analysis of NICE cancer drug appraisals
title Correction to: Will the reformed Cancer Drugs Fund address the most common types of uncertainty? An analysis of NICE cancer drug appraisals
title_full Correction to: Will the reformed Cancer Drugs Fund address the most common types of uncertainty? An analysis of NICE cancer drug appraisals
title_fullStr Correction to: Will the reformed Cancer Drugs Fund address the most common types of uncertainty? An analysis of NICE cancer drug appraisals
title_full_unstemmed Correction to: Will the reformed Cancer Drugs Fund address the most common types of uncertainty? An analysis of NICE cancer drug appraisals
title_short Correction to: Will the reformed Cancer Drugs Fund address the most common types of uncertainty? An analysis of NICE cancer drug appraisals
title_sort correction to: will the reformed cancer drugs fund address the most common types of uncertainty? an analysis of nice cancer drug appraisals
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6437939/
https://www.ncbi.nlm.nih.gov/pubmed/30922313
http://dx.doi.org/10.1186/s12913-019-4039-8
work_keys_str_mv AT morrellliz correctiontowillthereformedcancerdrugsfundaddressthemostcommontypesofuncertaintyananalysisofnicecancerdrugappraisals
AT wordsworthsarah correctiontowillthereformedcancerdrugsfundaddressthemostcommontypesofuncertaintyananalysisofnicecancerdrugappraisals
AT schuhanna correctiontowillthereformedcancerdrugsfundaddressthemostcommontypesofuncertaintyananalysisofnicecancerdrugappraisals
AT middletonmarkr correctiontowillthereformedcancerdrugsfundaddressthemostcommontypesofuncertaintyananalysisofnicecancerdrugappraisals
AT reessian correctiontowillthereformedcancerdrugsfundaddressthemostcommontypesofuncertaintyananalysisofnicecancerdrugappraisals
AT barkerrichardw correctiontowillthereformedcancerdrugsfundaddressthemostcommontypesofuncertaintyananalysisofnicecancerdrugappraisals

Ejemplares similares